Christopher White Email & Phone Number

Washington, District Of Columbia, United States

Chief Legal Officer and Chief executive responsible for all US & Global Policy affairs (Medtech regulatory, coverage/payment, global, legal, etc.). Lead Association's Board Strategic Planning activities; Secretary to the Board of Directors. Appointed to enhanced responsibilities following relaxation of interim COVID Action Leader surge/ interim responsibilities described below.

Washington, Dc

Chief legal officer, secretary to the Board of Directors and chief executive responsible for all corporate operations (IT, facilities, membership, governance, HR/talent development, corporate structure, legal). Appointed in March 2020 as organization's COVID-19 Action Team Leader, leading all COVID-19 related initiatives and policy. Guided organization to fully remote functioning upon onset of the pandemic. Provide counsel, executive judgment, strategic perspective, creative solutions and guidance across all functional areas. Devised and executed corporate acquisition & integration of Conference entity. Restructured Board governance to expand Board and increase Board effectiveness. Lead Association’s global legal and compliance policy work, including comprehensive industry Code of Ethics and program.

Washington D.C. Metro Area

Interim executive management committee member, General Counsel and Secretary: responsible for all Association affairs, reporting to Board Chairman, following CEO departure, and prior to new CEO hire.

Washington D.C. Metro Area

Chief legal officer of the association and secretary to the Board of Directors. Responsible for governance, HR and all legal affairs. Created and lead the association’s Legal Policy, Health Care Compliance/Code of Ethics activities to formulate and advance proactive legal positions on issues impacting patient access to medical technology. Testify before Congressional and State legislative committees. Frequent speaker on life sciences legal issues and domestic and global compliance, fraud & abuse and anti corruption issues. • Formed and lead 15 active legal and compliance working groups, of over 1500 medical device and diagnostics company lawyers • Structured and established AdvaMed’s China office; devised and structured AdvaMed’s corporate divisions (Dx, Accel)• Conceived of and oversaw multiple corporate governance reforms to achieve best practices• Oversee corporate risk management; manage sensitive government matters and talent transitions• Initiated, organize and manage annual overseas legal/compliance policy conferences in Europe, Asia and Latin America to advance business ethics http://www.gmtcc.com/ • Led working group of 80 industry lawyers to redraft AdvaMed’s industry Code of Ethics; led working groups to develop industry compliance and legal guidance documents on regulatory and anti-corruption issues; led legal working groups to draft China and Brazil Codes of Ethics• Led 40 member working group of Asia Pacific government officials and industry lawyers to draft Kuala Lumpur Principles, harmonizing self regulatory standards • Formed and led 40 lawyer industry team to develop IRS medical device tax guidance and exceptions• Chaired International conventions to achieve legal policy agreements (Nusa Dua Statement; Brazil MOU) • Co-chair, Expert Working Group on APEC (Asia Pacific) Anti Corruption Law harmonization

Washington, D.C.

Partner in the FDA/Healthcare Regulation Practice, focusing on Centers for Medicare and Medicaid Services (formerly Health Care Financing Administration) regulatory issues affecting medical technology innovators, including device manufacturers, biotechnology companies and behavioral health and other healthcare service providers. Counselled extensively on regulatory compliance and health care fraud and abuse and corporate compliance matters. Served as special health care counsel in governmental audits, civil and criminal investigations and prosecutions, administrative and exclusion proceedings, and internal audits and investigations. Pro Bono Representation of behavioral health facilities.

Washington, D.C.

Health Care Regulatory; Transactional, Corporate; Compliance/Fraud and Abuse (Washington, DC office)

Jd, Law

Activities and Societies: Journal of Contemporary Health Law and Policy

Ba, Biology

Concentration in Cell biology and electron microscopy